In this context, YBX1 forms ribonucleoprotein complexes with IGF2BPs on m6A -modified transcripts, stabilizing key oncogenic mRNAs such as MYC and BCL2 in acute myeloid leukemia (AML) (13). This evidence concerns the gene BCL2 and acute myeloid leukemia.